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Capture and enrichment of CD34-positive haematopoietic stem
and progenitor cells from blood circulation using P-selectin in an
implantable device
Haematopoietic progenitors represent a small but important
population of cells found in the blood circulation. These
multipotent adult stem cells differentiate into every major
blood cell type of the more than twenty trillion cells in the
bloodstream. The lifespan of various blood cells can range
from years for some lymphocytes, to months for erythrocytes,
to mere hours for neutrophils, making continuous production
of blood cells (haematopoiesis) necessary for even short term
homeostasis (Gunsilius et al, 2001). Unfortunately, many of
the most common cancer therapies are deleterious to haemat-
opoietic function or even destroy it outright. Collection and
enrichment of haematopoietic stem and progenitor cells
(HSPCs) for infused restoration of haematopoiesis remains
a vital means for cancer patient survival and a major area of
research (To et al, 1997; Gunsilius et al, 2001).
Current methods of HSPC isolation focus on the immuno-
logical binding characteristics of antibodies to speciﬁc surface
markers, such as CD34 or CD133, followed by separation using
magnetic beads or cell sorting. These collection procedures
result in a viable and speciﬁc population of HSPCs; however,
the incubation process is time consuming and often results in
contamination or inadequate cell yield. Less speciﬁc aphaeretic
techniques attempt to increase the HSPC yield but result in an
accompanying population of non-progenic cells that can be
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Summary
Clinical infusion of haematopoietic stem and progenitor cells (HSPCs) is vital
for restoration of haematopoietic function in many cancer patients.
Previously, we have demonstrated an ability to mimic physiological cell
trafﬁcking in order to capture CD34-positive (CD34
+) HSPCs using
monolayers of the cell adhesion protein P-selectin in ﬂow chambers. The
current study aimed to determine if HSPCs could be captured directly from
circulating blood in vivo. Vascular shunt prototypes, coated internally with
P-selectin, were inserted into the femoral artery of rats. Blood ﬂow through
the cell capture device resulted in a wall shear stress of 4–6 dynes/cm
2. After
1-h blood perfusion, immunoﬂuorescence microscopy and ﬂow cytometric
analysis revealed successful capture of mononuclear cells positive for the
HSPC surface marker CD34. Purity of captured CD34
+ cells showed
sevenfold enrichment over levels found in whole blood, with an average
purity of 28%. Robust cell capture and HSPC enrichment were also
demonstrated in devices that were implanted in a closed-loop arterio-venous
shunt conformation for 2 h. Adherent cells were viable in culture and able to
differentiate into burst-forming units. This study demonstrated an ability to
mimic the physiological arrest of HSPCs from blood in an implantable device
and may represent a practical alternative for adult stem cell capture and
enrichment.
Keywords: P-selectin, haematopoietic progenitor, CD34, adult stem cell,
implantable device.
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malignant cells following autologous donation, or graft-versus-
host disease (GVHD) following allogeneic donation (Horwitz
& Sullivan, 2006). Furthermore, new studies suggest that
immunologically separated HSPCs may lack an important
stem cell phenotype. This phenotype represents a more
primitive and less differentiated progenitor, which may be
better suited for the reconstitution of haematopoietic function
in the patient through improved engraftment rate and
shortened time for engraftment (Engelhardt et al, 2002; Guo
et al, 2003). Seemingly missing from the current landscape of
this essential clinical procedure is a technique for the isolation
of haematopoietic progenitors that lacks the negative aspects of
immunological-based separation.
Recently, our laboratory has demonstrated that HSPCs
exhibit a distinct behavioural phenotype when perfused over
monolayers of P-selectin in microchannels (Charles et al,
2007). Discrete behaviour of rolling HSPCs includes
decreased rolling velocity, decreased saltatory detachment,
and increased number of adherent cells when compared with
other blood cell types (such as leucocytes) ﬂowing over
similar monolayers. These observations support and extend
previous results from another laboratory that showed similar
behaviour by CD34-positive (CD34
+) cells rolling on
L-selectin substrates (Greenberg & Hammer, 2001). Selec-
tin-mediated cell adhesion is a ubiquitous form of cell
trafﬁcking in the body. This mode of adhesion plays a major
role in the arrest of cells from ﬂow during vital physiological
events, such as the tethering of neutrophils on the venular
endothelium during the inﬂammatory response (Ley et al,
1995; Konstantopoulos et al, 2003; Kim & Sarelius, 2004), the
capture of lymphocytes during the acquired immune defence
(Springer, 1994), and the recently observed adhesion of
leucocytes in arterioles (Sumagin & Sarelius, 2006). Further-
more, selectins are primary adhesion molecules for the
homing of circulating HSPCs to the bone marrow during
natural haematopoiesis (Schweitzer et al, 1996; Frenette et al,
1998; Peeled et al, 2000).
The aim of the current study was to determine if P-selectin
could be used to capture and enrich a population of HSPCs
from whole blood in the living animal. The inside lumenal
surface of a blood-compatible plastic tube was coated with
P-selectin and the tube was implanted into the femoral artery
of an anesthetized rat to determine if CD34
+ HSPCs could be
captured from the circulation. Blood ﬂow through implanted
cell capture tubes coated with P-selectin enabled the collec-
tion of HSPCs with signiﬁcant enrichment over the concen-
tration found in whole blood. The captured HSPCs were
viable and demonstrated a haematopoietic progenitor phe-
notype with an ability to differentiate into burst-forming
units (BFU). We hypothesize that ﬂow-mediated capture of
HSPCs with P-selectin may represent a practical and more
physiological alternative to HSPC isolation than the static
immunological or density-mediated protocols currently used
in the clinic.
Materials and methods
Preparation of implantable cell capture tubes
Under aseptic conditions, human recombinant P-selectin/Fc
chimera (R&D Systems, Minneapolis, MN, USA) was
adsorbed to the inside lumen of blood-compatible plastic
tubing (inside diameter = 300 lm, length 50 cm, MicroRena-
thane MRE-025; Braintree Scientiﬁc Inc., Braintree, MA, USA)
with a 2-h incubation of P-selectin solution (20 lg/ml or
40 lg/ml) diluted in Dulbecco’s phosphate-buffered saline
(PBS, GIBCO, Grand Island, NY, USA) at room temperature
with one exchange of the solution midway through the
incubation. Following a gentle PBS wash, non-speciﬁc block-
ing of the lumen surface was achieved with a 1-h incubation of
either 5% sterile bovine serum albumin (BSA, Sigma-Aldrich,
St. Louis, MO, USA) or 5% sterile milk protein (Nestle USA,
Solon, OH, USA) dissolved in PBS. Following another PBS
wash, the P-selectin layer was maintained in calcium-enriched
Hanks’ balanced salt solution [2 mmol/l Ca
++] (HBSS,
GIBCO) until surgical implantation. Previous in vitro exper-
iments have demonstrated that this adsorption procedure is
effective for P-selectin mediated physiological rolling of cell
populations (Charles et al, 2007). Similarly, separate tubes
were prepared with a 2-h incubation of CD34 antibody
(100 lg/ml, Santa Cruz Biotechnology, Santa Cruz, CA, USA)
instead of P-selectin. Control tubes were prepared with a 2-h
incubation of PBS only, followed by similar non-speciﬁc
blocking.
Surgical implantation of the device
Adult male Sprague-Dawley rats (Charles River Laboratories,
Wilmington, MA, USA; body weight = 331 ± 6Æ2 g) were
injected subcutaneously with granulocyte colony-stimulating
factor (GCSF, Filgrastim, Amgen, Thousand Oaks, CA, USA)
at 80 lg/kg body weight, daily for 3 d prior to surgery. In
studies of human peripheral blood, the fraction of mononu-
clear cells (MNCs) positive for CD34 was typically less than
0Æ5% (Tong et al, 1994; de Wynter et al, 1998). GCSF-
mobilization can increase this fraction to 1–2% or higher
(Kim, 2003; Fietz et al, 2004; Nomura et al, 2004). Surgical
procedures were performed under anaesthesia (pentobarbital
sodium 26 mg/kg with chloral hydrate 128 mg/kg, intraperi-
toneal administration) using aseptic conditions as previously
described (Blair & Mickelsen, 2006a,b). All experimental
procedures were reviewed and approved by the University of
Rochester’s institutional animal care and use committee.
Two types of experiments were performed. In the ﬁrst,
animals were prepared for implantation of the cell-capture
device via exposure of the right femoral vein and left femoral
artery. A catheter was inserted into the right femoral vein for
injection of supplemental anaesthetic. The left femoral artery
was ligated distal to the point of tubing insertion. One end of
the tubing was then inserted into the femoral artery through
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towards the heart so that the tip of the tubing was in the aorta,
1–5 mm above the iliac bifurcation. A small bolus of the
anticoagulant sodium heparin (150 ll, 1000 units/ml; Baxter
Healthcare Co., Deerﬁeld, IL, USA) was administered via the
venous catheter, immediately after blood began to ﬂow
through the device tubing. Measurement of ﬂow rate through
the tube was accomplished via collection of outﬂow blood over
timed intervals. Total blood ﬂow through the tube was
approximately 5 ml over a 1-h period, representing about
20% of the total blood volume of the rat (Blair & Mickelsen,
2006b). At the end of the 1-h perfusion period, the outﬂow
end of the tubing was occluded and the cell capture device was
withdrawn and prepared for analysis.
In the second set of experiments, the device was incorpo-
rated into the rat circulation via a closed-loop arterio-venous
shunt, allowing blood that ﬂowed through the device to
recirculate. Animals utilized for these experiments were
prepared identically to those used for the 1-h perfusion
experiments, except that the outﬂow end of the tube was
inserted into the left femoral vein and advanced approximately
2 cm into the vena cava. In this way, blood entered the tubing
from the arterial circulation and then returned to the animal’s
circulation from the venous end of the tubing. Following a 2-h
period of blood ﬂow through the cell capture device, the
venous end of the tubing was occluded and the device was
removed for analysis.
All animals were maintained in an anesthetized state
throughout the procedure and were euthanized with an
overdose of anaesthesia.
Collection and analysis of captured cells
Following removal from the rat’s circulation, cell capture tubes
were positioned on an inverted IX-81 epi-ﬂuorescence micro-
scope (Olympus USA, New York, NY, USA) coupled to an
intensiﬁed CCD camera (SensiCam QE, Cooke PCO, Auburn
Hills, MI, USA) and brightﬁeld CCD camera (Hitachi Kokusai
Electronic Inc., Tokyo, Japan) for direct visualization of the
adherent cells in the tube lumen. Tubes were rinsed of residual
blood and non-adherent cells with a gentle wash of HBSS
[2 mmol/l Ca
++] for 20 min (0Æ5 dynes/cm
2). Twenty repre-
sentative ﬁelds were imaged to determine adherent cell
concentration in the capture tube. Adherent cells were then
further analysed either by direct ﬂuorescent visualization or by
ﬂow cytometry, or were utilized in cell culture experiments to
characterize expansion as described in the following section.
For capture tubes evaluated by direct visualization, the tube
lumen was incubated for 30 min with a monoclonal antibody
against the haematopoietic stem cell surface marker CD34
(Santa Cruz Biotechnology) conjugated to quantum dots
(Qdot 605, Molecular Probes, Eugene, OR, USA). Following
a gentle rinse, representative ﬁelds were imaged and analysed
for CD34-positive cells determined by increased ﬂuorescence
intensity relative to CD34-negative leucocytes.
For capture tubes evaluated with quantitative ﬂow
cytometry analysis of CD34-positive cells, adherent cells were
extracted from the tubes using increased shear rate and air
embolism. Cells were then split into equal samples and
incubated for 30 min with either CD34 antibody (Santa Cruz
Biotechnology) or matched isotype control antibody (Santa
Cruz Biotechnology). Following wash and resuspension, cell
fractions were run on the FACSCalibur system (Becton-
Dickinson, San Jose, CA, USA). Cytometric data was analysed
using FACSCalibur software on a Macintosh G3 computer
(Apple Inc., Cupertino, CA, USA). Quantiﬁcation of the
CD34-positive cell population of peripheral blood in GCSF-
mobilized and non-mobilized rats was determined through
ﬂow cytometric analysis of erythrocyte-lysed blood from the
same animals in which cell capture tubes were implanted.
Expansion of captured haematopoietic stem cells
In experiments performed on a separate group of implanted
rats, adherent blood-borne cells were extracted from P-selectin
capture shunts (40 lg/ml) and screened for viable haemato-
poietic progenitors using a colony-forming cell (CFC) assay
(HSC005, R&D Systems). Brieﬂy, following positive trypan
blue staining of a separate fraction, 10
5 cells in 100 ll were
mixed with 1 ml methylcellulose enriched media. Cells were
plated in six-well plates and incubated at 37 C, 5% CO2 for up
to 28 d. For a comparison of same-species haematopoietic
progenitor expansion, MNCs were extracted from rat whole
blood via Ficoll gradient separation and plated in the same
manner (separate platings of 10
5 and 10
6 cells). Following
14 d, BFU and colony-forming units (CFU) were observed,
counted, and imaged under the microscope for up to 28 d.
Statistics
Statistical analysis of MNC capture density and CD34
+ cell
purity for 1-h perfusion experiments was performed by
analysis of variance (anova), followed by Holm-Sidak post
hoc comparisons between individual experimental groups
(SPSS SigmaStat 3.0 software, SPSS, Inc., Chicago, IL, USA)
using an overall signiﬁcance level of P <0 Æ05. All other data
were analysed by Student t-test (Prism 3.0; GraphPad Software,
San Diego, CA, USA) at a level of signiﬁcance P <0 Æ05. Data
are presented as the mean ± SE.
Results
MNC adhesion to implanted capture tubes
To facilitate cell capture on the implanted device surface using
physiological ﬂow-mediated mechanisms, tubes with lumenal
surfaces adsorbed with P-selectin were incorporated into blood
circulation via insertion into the femoral artery of anesthetized
rats. This permitted blood to be redirected from the rat’s
circulationintothecapturedevice,withﬂowthroughthetubing
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stressenvironmentatthecapturesurfaceforcelladhesion,atube
lengthof50 cmwasusedtoproducetheappropriatevolumetric
ﬂow given ﬂuid resistance and blood pressure. The average ﬂow
rate through the implanted tubes was 81Æ5±2 Æ2 ll/min
(mean ± SE, n = 47 rats), corresponding to a wall shear stress
of approximately 5 dynes/cm
2. Following extraction and gentle
washing of residual erythrocytes and non-adherent cells, the
number of adherent MNCs (including polymorphonuclear or
PMN cells) was quantiﬁed by direct microscopy. Lumenal
surfaces of tubes coated with P-selectin or antibody against
CD34 showed robust and sustained adhesion of MNCs when
compared to non-coated control tubes. Figure 1 demonstrates
the ability of adhesion molecule-coated tubes to capture blood-
borne nucleated cells over a 1-h period during which blood
ﬂowed directly from the rat’s circulatory system through the
capture tube. Tubes that had been incubated with 20 lg/ml or
40 lg/ml P-selectin captured an average of over 34 000 and
87 000 nucleated cells, respectively, corresponding to surface
concentrations of 72Æ7±1 6 Æ9 cells/mm
2 (n = 5) and
184Æ6±1 9 Æ9 cells/mm
2 (n = 6). Tubes with capture layers
comprised of adhesion molecules all showed signiﬁcantly
increasedMNCadhesionwhencomparedtonon-coatedcontrol
tubes, which showed little cellular arrest (4Æ7±1 Æ4 cells/mm
2,
n = 6).Similarconcentrationsofplateletswereadherentinboth
P-selectin coated tubes and in control tubes (as observed in
Fig 1A and B).
Successful adsorption of P-selectin to the tubes during
incubation was veriﬁed with a protein deposition assay that
established a minimum of 55% of the soluble P-selectin
chimera being taken up by the capture surface using 40 lg/ml
P-selectin solution (data not shown). A P-selectin solution of
20 lg/ml resulted in deposition of at least 65% of the adhesion
molecule. Overall cell adhesion was similar between upstream
and downstream ends of the capture tubes, supporting existing
evidence that mechanisms of adhesion during blood cell
recruitment take place on the micrometre length scale (Kunkel
et al, 2000; King et al, 2003; Kim & Sarelius, 2004).
Capture of CD34-positive haematopoietic stem cells
To determine if P-selectin coated tubes successfully captured
blood-borne HSPCs, the captured cell population was labelled
with an antibody against the HSPC surface marker CD34
conjugated to ﬂuorescent quantum dots. We observed paired
images ofthetube’slumenalsurfaceundertrans-brightﬁeldand
epi-ﬂuorescence illumination. Despite a small amount of
unavoidable autoﬂuorescence from the tube material itself,
brightCD34-positivecellswereclearlyevidentamongnucleated
CD34-negative cells captured from the bloodstream (Fig 2).
In experiments conducted to fully quantify HSPC capture
using ﬂow cytometry, captured cell populations were extracted
from tubes and stained with a ﬂuorescent antibody against
CD34 (paired samples stained with matched isotype antibody
were analysed as a control). Figure 3A illustrates representative
ﬂow cytometric forward- and side-scatter data of the extracted
cells from an implanted tube coated with P-selectin, with gates
established to discern captured MNCs from debris and smaller
adherent platelets. Immunoﬂuorescence ﬂow cytometric anal-
ysis revealed that, when compared to matched-isotype control
P-selectin capture tube (40 µg/ml)
Control tube
(A)
(B)
(C)
Fig 1. Direct capture of blood-borne nucleated cells from circulation using P-selectin and non-coated control surfaces in implanted devices.
Following incorporation into the femoral artery of anesthetized rats and 1-h blood perfusion, P-selectin coated tubes (A) showed a signiﬁcantly
greater average concentration of captured nucleated cells than non-coated control tubes (B) [184Æ6±1 9 Æ9 cells/mm
2 for P-selectin tubes (40 lg/ml)
vs. 4Æ7±1 Æ4 cells/mm
2 for control surfaces (P <0 Æ01), bar = 50 lm]. (C) Total cell yields from 50 cm implanted tubes with cell adhesion molecule
surfaces were signiﬁcantly greater than the yield from non-speciﬁc binding in control tubes (**P <0 Æ01).
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distinct population of CD34
+ cells (Fig 3b). Quantiﬁcation of
the ability of implanted tubes to capture CD34
+ cells was
determined by measuring CD34
+ cell purity, deﬁned as the
percentage of captured CD34
+ cells to total captured MNCs.
Figure 4 illustrates the average level of CD34
+ cell purity from
each implantable cell capture tube type compared with that of
circulating blood in rats. Purity of CD34
+ cells on non-coated
control tubes was similar to that found in blood circulation
[4Æ3±0 Æ3% vs. 3Æ9±0 Æ6% for control tubes (n = 3 rats) and
whole rat blood (n = 5), respectively]. Conversely, capture
tubes coated with cell adhesion molecules had robust cell
adhesion and signiﬁcantly higher CD34
+ cell purity. For
example, tubes incubated with 20 lg/ml and 40 lg/ml
P-selectin resulted in an average purities of 10Æ3±1 Æ3%
(n = 4) and 27Æ8±3 Æ0% (n = 6), respectively, the latter
(A) (B)
Fig 3. Flow-cytometric analysis of the adherent blood-borne cells from implanted tubes indicated a distinct population of CD34-positive cells on the
capture surface. (A) Following extraction from the cell-capture tube, adherent mononuclear cells (MNCs) were analysed for surface expression of
CD34 (the left-hand region of smaller platelets was excluded from analysis). (B) Immunoﬂuorescent ﬂow cytometric analysis of captured cells
revealed a distinct population of MNCs positive for CD34 (arrow, subpopulation represents 38% of total MNCs) when compared to cells stained with
isotype control antibody (bold line).
Trans-illuminated  Epi-fluorescent
Site A
Site B
Site C
Fig 2. Paired brightﬁeld and epi-ﬂuorescence images of captured cells
immunostained for CD34. Comparison of representative paired
brightﬁeld and ﬂuorescent images of adherent cells immunolabelled
with an antibody against a hematopoietic stem cell surface marker
conjugated to quantum dots revealed blood-borne CD34-bright cells
(white arrows) distinctly visible among CD34-dark cells on the capture
surface (bar = 50 lm). Quantitative analysis conﬁrmed a sixfold
enrichment in the purity of CD34-positive cells on P-selectin surfaces
over the proportion found in rat whole blood.
Fig 4. Purity of CD34-positive cells on implanted cell-capture devices
with various adhesion-molecule surfaces and in whole blood of gran-
ulocyte colony-stimulating factor (GCSF)-mobilized and non-mobi-
lized rats. As expected, the presence of CD34-positive cells was
signiﬁcantly higher in whole blood of GCSF-mobilized rats versus their
non-mobilized counterparts (P <0 Æ05). Following incorporation into
the femoral artery of anesthetized rats and 60-min blood perfusion,
purity of CD34-positive cells among mononuclear cells captured using
P-selectin was elevated sevenfold over that of whole blood and non-
coated control surfaces. CD34
+ cell-purity in tubes incubated with
40 lg/ml P-selectin was signiﬁcantly greater than that from capture
surfaces coated with less P-selectin, and was similar to surfaces coated
with CD34 antibody (*P <0 Æ05).
In vivo capture of CD34
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+ cells over whole
blood (Fig 4). Tubes incubated with antibody to CD34
(100 lg/ml) elicited a CD34
+ cell purity that was similar to
P-selectin tubes (27Æ2±7 Æ3%, n = 4). However, as shown in
Fig 1, CD34 antibody tubes exhibited inferior ﬂow-mediated
cell capture when compared to P-selectin tubes (40 lg/ml).
The similarity in purities between non-coated control tubes
and whole blood establishes two important points when
considering cellular capture and enrichment within P-selectin
tubes. First, non-coated control tubes showed dramatically less
cellular adhesion than tubes designed for active capture (by
nearly two orders of magnitude), indicating that non-speciﬁc
cellular adhesion is inconsequential and does not contribute to
the CD34
+ cell enrichment on active capture surfaces. Second,
the fact that non-speciﬁc binding, though minimal, results in
CD34
+ purity similar to that in whole blood, suggests that
CD34
+ enrichment in P-selectin tubes is the result of the
speciﬁc molecular interactions governing cellular adhesion.
Capture of haematopoietic stem cells in fully implanted
arterio-venous devices
Finally, in separate experiments, cell capture tubes were
completely incorporated into the circulatory system of the rat
via arterio-venous shunt, allowing blood that entered the
tubing from the arterial circulation to be returned to the
animal’s circulation from the downstream (venous) end of
the tubing over a 2-h time period of continuous perfusion.
MNC capture and CD34
+ cell purity were compared with that
from tubes inserted into the femoral artery of the rat and
perfused, as before, for 1 h with a single pass of blood.
Figure 5 illustrates that, similar to previous experiments, the
capture of MNCs in 50-cm P-selectin tubes (40 mg/ml) with
a 1-h single blood-pass was maintained at over 84 000 cells,
or 178Æ3±3 3 Æ8 cells/mm
2 (n = 6). Two-hour perfusion
through the arterio-venous recirculation shunts resulted in
the arrest of nearly 160 000 MNCs, or 338Æ0 ± 115Æ0 cells/
mm
2 (n =7 ;P >0 Æ05). Purity of captured populations for
CD34
+ cells were 16Æ2±5 Æ5% and 21Æ0±6 Æ6% for 1- and 2-h
experiments, respectively. These results conﬁrm that targeted
cell capture also occurs in a fully implanted arterio-venous
recirculation device, and suggest that the amount of capture
and degree of purity might be increased with longer times of
perfusion.
Viability and expansion of haematopoietic stem cells
The enriched population of blood-borne cells on the device
surface was screened to verify the ability to capture and
maintain viable progenitors with haematopoietic colony-
forming potential. Cells extracted from implanted P-selectin
tubes (40 lg/ml) showed over 90% viability and were
expanded in culture using a CFC assay. Six-well plates were
seeded at a concentration of 10
5 P-selectin tube-captured cells,
as well as concentrations of 10
5 and 10
6 MNCs isolated from
rat peripheral blood. Figure 6 compares representative images
from 3 to 4-week-old cultures of cells obtained from P-selectin
capture tubes (Fig 6A, C, and E) with MNCs from whole rat
blood known to contain populations of healthy HSPCs
(Fig 6B, D, and F). In both groups, hemoglobinized erythro-
blasts and granulocyte/monocyte precursors were observed in
both BFU and CFU (BFU-E and CFU-GM).
Table I demonstrates the haematopoietic expansion of
HSPCs, given as the number of BFU-E and CFU-GM colonies
after 3–4 weeks. HSPCs from P-selectin tubes were observed to
expand similarly to HSPCs from whole blood when plated at
(A) (B)
Fig 5. Mononuclear cell (MNC) capture and CD34-positive cell purity from implanted cell-capture devices inserted into the rat femoral artery and
perfused with a single-pass of blood for 1 h, or incorporated completely into the circulatory system of the rat via arterial-venous shunt for continuous
2-h recirculation. (A) The average capture of MNCs in 50 cm P-selectin tubes (40 lg/ml) was 84 036 cells (178Æ3±3 3 Æ8 cells/mm
2, n = 6) for 1-h
single blood-pass and 159 264 cells (338Æ0 ± 115Æ0 cells/mm
2, n = 7) for 2-h recirculation. (B) Purity of captured MNC populations for CD34
+ cells
was 16Æ2±5 Æ5% and 21Æ0±6 Æ6% for 1- and 2-h experiments, respectively. The results conﬁrm that targeted cell capture also occurs in a fully
implanted arterio-venous recirculation device, and suggest that the amount of capture and degree of purity might be increased with longer times of
perfusion.
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plating of 10
5 cells for expansion (dictated by the cell yield of
our device) and the use of a cross-species colony assay (due to
unavailability of rat-speciﬁc CFC media) were seemingly
limiting factors to colony expansion, the presence of robust
erythroid and granulocyte/monocyte colonies indicates that
implantable P-selectin tubes have the capacity not only for
HSPC capture and enrichment, but also for short-term
maintenance of viable progenitors with the potential for
differentiation and proliferation.
Discussion
We have demonstrated an ability to capture and enrich
haematopoietic stem cells from the bloodstream of a living
animal using P-selectin in an implanted device. To our
knowledge, the current study represents the ﬁrst time that
P-selectin has been used to sequester adult stem cells directly
from circulation in vivo, rather than through immunological
or density gradient processing of blood samples. This ﬂow-
based system mimics physiological events involved in normal
cellular trafﬁcking, such as the recruitment of leucocytes
during the inﬂammatory response or homing of HSPCs to the
bone marrow. The enriched population of captured HSPCs
showed signiﬁcantly increased purity over the population
found in whole blood or on control surfaces. Moreover,
extracted cells were viable and could be expanded in culture to
produce BFU and CFU. This approach represents a possible
alternative to the current HSPC enrichment protocols that are
widely utilized in the clinic as an adjunct to speciﬁc cancer
therapies.
Findings from the current study support and extend
previous work from our and other laboratories demonstrating
capture of CD34
+ cells on selectin surfaces in isolated systems
(Greenberg & Hammer, 2001). We speculate that signiﬁcant
enrichment of CD34
+ cells from the bloodstream in an
implantable device, especially in an environment ﬁlled with
abundant binding competitors, such as leucocytes, is facilitated
by differences in afﬁnity and adhesion kinetics between cell
types in the heterogeneous population of blood. Earlier work
in our laboratory has shown that populations of CD34
+ cells
exhibit a rolling phenotype that is quite different from that of
leucocytes or other CD34) cells when interacting with selectins
in ﬂow microchannels (Charles et al, 2007). In those studies
CD34
+ cells were observed to have lower rolling velocities,
decreased saltatory behaviour, and lower detachment rates
than leucocytes perfused over the same surface. Additional
studies have shown that within venular microvessels in situ,
leucocyte attachment is quite transient and short-lived (Woj-
ciechowski & Sarelius, 2005; Ryschich et al, 2006). Under
unstimulated or lightly-activated conditions, up to 90% of
adherent leucocytes are known to detach into the bulk ﬂow
within 15 min of initial capture (Wojciechowski & Sarelius,
Table I Hematopoietic expansion potential of hematopoietic stem and progenitor cells (HSPCs) from P-selectin capture tubes and peripheral blood,
given as the number of hemoglobinized erythroblasts and granulocyte/monocyte precursors were observed in both BFU and CFU colonies after 3–
4 weeks.
Hematopoietic Colony Type P-selectin Captured MNCs (10
5 cells) Peripheral Blood MNCs (10
5 cells) Peripheral Blood MNCs (10
6 cells)
CFU-GM (# colonies) 1.5 (2 of 5 plates active) 1.5 (2 of 7 plates active) 14.4 (5 of 6 plates active)
BFU-E (# colonies) 1.5 (2 of 5 plates active) 0.5 (2 of 7 plates active) 4.0 (5 of 6 plates active)
Viable blood-borne HSPCs from implanted P-selectin coated tubes and rat whole blood expand to similar numbers of colony-types in culture (counts
are given as average number of colonies per active plate). The presence of erythroid and granulocyte/monocyte colonies indicates that implantable P-
selectin tubes have the capacity not only for HSPC capture and enrichment, but also for short-term maintenance of viable progenitors with the
potential for differentiation and proliferation.
(A) 
(C) 
(B) 
(D) 
(E)  (F) 
From implanted cell-capture tubes From whole blood
Fig 6. Bright ﬁeld microscopic images of erythroid burst-forming
units and granulocyte/monocyte colony forming units, expanded from
hematopoietic stem cells (HSCs) harvested from implanted cell capture
tubes and whole blood. Viable blood-borne HSCs from implanted P-
selectin coated tubes (A, C, and E) and rat whole blood (B, D, and F)
were expanded in culture for up to 28 d. Robust colonies were ob-
served from HSCs in each group.
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blood-borne cells may occur initially, over time the different
binding kinetics of the various cell types are likely to result in
a more enriched population of adherent cells, such as HSPCs.
In other words, we surmise that the enrichment of CD34
+ cells
on the capture layer is a consequence of a temporally evolved
system in which leucocytes or other MNCs are displaced over
time by HSPCs having greater adhesion and lower detachment
rates. The potential clinical applicability of this device is
further supported by results from the current study demon-
strating robust MNC capture and enriched CD34
+ cell purity
in capture tubes implanted as an arterio-venous shunt through
which blood could be returned to circulation. Longer-term
temporal dependence of HSPC binding will be examined
further in future studies where capture tubes will be incorpo-
rated into blood circulation on the order of days.
Despite signiﬁcant enrichment of HSPCs from circulating
blood in the current study, it is likely that modiﬁcation and
optimization of the system would result in further increased
target cell purity and yield. As an example, while the length of
our system was chosen to facilitate ﬂow rates and shear stresses
amenable to selectin-mediated cell capture (on the order of
5 dynes/cm
2), the cross-section of the current system was
matched to the anatomical diameter of the femoral artery of
the rat. A decrease in the diameter of the ﬂow tubes to less than
100 lm, with a length-width geometry adjusted for optimal
shear stress, should result in hemodynamic effects more
favourable for blood-borne cell capture, such as enhanced
margination. This, in turn, would enable a larger survey of
nucleated cells in bulk ﬂow and a potential increase in the
capture of stem cells.
One measure of potential efﬁcacy of our system is demon-
strated by comparing the CD34
+ cell purity achieved using
P-selectin with that of cell-capture surfaces comprised of an
antibody against a stem cell surface marker directly. In this
manner,theaveragepurityachievedwithourP-selectintubesin
a non-optimized geometry matched that achieved using anti-
body against CD34. It is possible that the achievable purity of
CD34
+ cells in optimized selectin capture devices could surpass
those of antibody capture devices as a result of the preferred
ﬂow-mediated nature of selectin binding versus that of anti-
bodies,whoseuseinaﬂow-mediatedsystemislessthanoptimal
because of the longer time required for bond formation.
The use of P-selectin for ﬂow-mediated enrichment of
haematopoietic progenitors holds the potential not only to
improve on current cell-isolation techniques in basic science
and laboratory animal research (as we have shown), but holds
a potential for translation to human beneﬁt in the clinic.
Results from recent studies have shown that positive screening
for haematopoietic progenitors can reduce the tumour cell
load during autologous donation and may play a role in
minimizing infusion-related toxicity (Shpall et al, 1997; Mohr
et al, 1999; Kasow et al, 2007). Additionally, there is compel-
ling evidence to suggest that puriﬁcation of CD34
+ progenitors
during allogeneic donation effectively minimizes GVHD and
may reduce relapse incidence (Lang et al, 2003; Lee et al,
2005). Thus, the use of a ﬂow-mediated system for haemat-
opoietic progenitor enrichment maintains the potential to be
applied across autologous and allogeneic donor origins.
Moreover, because our cell-capture system mimics the same
selectin-mediated trafﬁcking used by the body to induce
engraftment of haematopoietic progenitors in the bone
marrow, we hypothesize that its use may not only carry with
it the demonstrated beneﬁts of haematopoietic progenitor
enrichment, but may elicit an improved clinical response
through the capture of a superior population of stem cell – a
population possibly overlooked by immunological separation
techniques. We reason that the ideal method to capture cells
intended for engraftment to the haematopoietic niche, is to
simulate the very conditions of selectin-mediated trafﬁcking
within the target tissue in situ.
In summary, our study demonstrates an ability to directly
capture and enrich a small but important population of blood-
borne cells from circulation using P-selectin in an implantable
device. Selective capture of HSPCs resulted in enrichment of
up to sevenfold over the population found in whole blood.
Extracted cells were viable and able to be expanded in culture
to promote differentiated haematopoietic colonies. These
results not only represent a potential alternative approach to
stem cell enrichment for both research and clinical purposes,
but also suggest a method to target other rare populations of
circulating cells such as cancer cells in vivo.
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